Evaluation of dynamin 2 knockdown as a therapeutic strategy for RYR1 related myopathy

Authors:

Abstract
No abstract available
Funding Information
  • Ionis Pharmaceuticals
  • National Institutes of Health (AR078000, CIHR 153056)

This publication has 21 references indexed in Scilit: